Hutchmed (China) Limited reports that it has finished the rolling submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for fruquintinib, a highly potent and selective oral inhibitor of VEGFR-1, -2, and -3, for…
Tag: clinical trial
The US Food and Drug Administration has approved the company’s investigational new drug (IND) application for CABA-201, a fully human CD19-CAR T cell investigational therapy that contains the 4-1BB protein, according to Cabaletta Bio, Inc., a clinical-stage biotechnology company focused…
Clinical Research department in Teva supports Protocols, Bioanalysis, CDISC, Final Reports, eTMF, Data Management. It also provides bioanalysis to support Teva studies in various other countries. Teva India Clinical Research team does monitoring to support Teva Israel/ Europe & US…
Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production facility and GLP qualified stringent quality control. The path of…
Sitero is an emerging leader in Clinical services and software solutions for the life sciences industry. We have experience and expertise in a diverse range of therapeutic areas and focus on innovative, technology-enabled solutions that allow our clients to focus…
Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer’s areas of business include pharmaceuticals; consumer healthcare products, agricultural chemicals, seeds and biotechnology products. Name of…
Global professional services provider Accenture has industry-leading expertise in digital, cloud, and security. We provide Strategy and Consulting, Technology and Operations services, and Accenture Song, all powered by the greatest global network of Advanced Technology and Intelligent Operations centres, combining…
The second preplanned interim analysis of Baudax Bio, Inc.’s phase 2 trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery showed promising results. Baudax Bio, Inc. is a pharmaceutical company that specialises in developing novel products for…
The US Food and Drug Administration (FDA) has designated NTLA-2002 for the treatment of hereditary angioedema as a Regenerative Medicine Advanced Treatment (RMAT), according to Intellia Therapeutics, Inc., a leading clinical-stage genome editing business (HAE). NTLA-2002 is a CRISPR-based in…
First patient dosed in phase 1 clinical study (NCT05482893) of PT886, a first-in-class native IgG-like bispecific antibody (bsAb) targeting claudin 18.2 and CD47 for the treatment of gastric, gastroesophageal junction, and pancreatic adenocarcinomas, according to Phanes Therapeutics, Inc. (Phanes), an…
